Dialog Box

What is CF?

Cystic fibrosis is a genetic condition

Cystic fibrosis (also called CF) is the most common, life-limiting genetic condition affecting Australians. 

CF causes an abnormal build-up of thick and sticky mucus in the lungs, airways and digestive system. Treatment requires intensive daily physiotherapy to clear the lungs and airways, countless medications and frequent hospitalisations.

Find out more Get support

Living with CF

Everyone's experience with CF is different

Children

Learn more about CF so you can be confident in managing your child's condition.

Read more
Young People

During your teenage years, you start to take over more management of CF from your family.

Read more
Adults

Tools, information and advice to support you to live your life while managing CF.

Read more
Carers

When you care for someone living with CF, looking after yourself needs to be important part of the plan.

Read more


Fundraise for us

It takes a community to care for CF

Every donation received and every dollar raised no matter how big or small, has the power to make a difference to the life of someone living with cystic fibrosis. All funds raised for Cystic Fibrosis Community Care help us to deliver support services and improve the lives of people living with CF, their families and carers.

Fundraise Donate

Our impact

We provide practical support

635

 subsidised items of physiotherapy equipment

5,533

responses to requests for information, support & advocacy

167

responses to requests for emergency financial assistance

188

responses to requests for education support

Who are the people living with Cystic Fibrosis?

3,500 people are living with CF in Australia and 1 in 25 people carry the recessive CF gene change. Babies born today with CF can expect to live well into adulthood. There is no cure but advances in treatment and care are helping people to better manage their condition.




Latest News View all news

News

Loxegen's nanoparticle gene therapy for cystic fibrosis (CF) has secured a significant $1.5 million grant from the Australian Government’s $230m Medical Research Future Fund (MRFF), with additional contributions pushing the total funding to over $3million

News

In Australia, as across the globe, the rising cost of living continues to be a pressing concern for many, significantly affecting those living with chronic conditions such as cystic fibrosis (CF).

News

Stephanie Quattromani, Head of Programs and Research at CFCC, recently attended the North American Cystic Fibrosis Conference (NACFC). Here she recaps the highlights from the conference and recent trends in research.

News

This year, we've seen remarkable strides in awareness, advocacy and community support. Every small victory is a leap towards a greater goal.

Donate